$1.39
-0.01-0.71%
Last update: Aug 10, 9:29 AM
Dare Bioscience (DARE) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.31 | $-0.35 | $-0.36 | $-0.57 |
| Actual | $-0.20 | $-0.02 | $-0.28 | $-0.45 |
| Surprise | +35.5% | +94.3% | +22.2% | +21.1% |
| Revenue | ||||
| Estimate | $601600 | $1.0M | $21850 | $312900 |
| Actual | $152455 | $1.0M | $2262 | $0 |
| Surprise | -74.7% | -0.68% | -89.6% | -100.0% |
| Metric | Q2 '26E | Q3 '26E | Q4 '26E |
|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||
| Consensus | $-0.30 | $-0.16 | $-0.29 |
| Revenue | |||
| Consensus | $2000 | $2.5M | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | May 14, 2026 | $-0.20 | $-0.31 | 35.5 % |
| Q4 | Mar 26, 2026 | $-0.02 | $-0.35 | 94.3 % |
| Q3 | Nov 13, 2025 | $-0.28 | $-0.36 | 22.2 % |
| Q2 | Aug 14, 2025 | $-0.45 | $-0.57 | 21.1 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | May 14, 2026 | $152.46K | $601.60K | -74.7 % |
| Q4 | Mar 26, 2026 | $1.02M | $1.03M | -0.68 % |
| Q3 | Nov 13, 2025 | $2.26K | $21.85K | -89.6 % |
| Q2 | Aug 14, 2025 | $0 | $312.90K | -100.0 % |